Related references
Note: Only part of the references are listed.Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Claire M. Patterson et al.
COMMUNICATIONS BIOLOGY (2021)
Nuclear localization of p65 reverses therapy-induced senescence
Sameer Salunkhe et al.
JOURNAL OF CELL SCIENCE (2021)
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
Valerie J. Carpenter et al.
CANCERS (2021)
Expression of therapy-induced senescence markers in breast cancer samples upon incomplete response to neoadjuvant chemotherapy
Tareq Saleh et al.
BIOSCIENCE REPORTS (2021)
Single cell biomass tracking allows identification and isolation of rare targeted therapy-resistant DLBCL cells within a mixed population
Graeme F. Murray et al.
ANALYST (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity
Estela Gonzalez-Gualda et al.
AGING CELL (2020)
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti et al.
CELL (2020)
BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response inTP53wild-type breast cancer
Ashkan Shahbandi et al.
CELL DEATH AND DIFFERENTIATION (2020)
A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells
Masahiro Wakita et al.
NATURE COMMUNICATIONS (2020)
Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells
Thanakorn Pungsrinont et al.
CELL AND BIOSCIENCE (2020)
Therapy-Induced Senescence: An Old Friend Becomes the Enemy
Tareq Saleh et al.
CANCERS (2020)
DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity
Nicolas Malaquin et al.
CELLS (2020)
Preclinical antitumor efficacy of senescence -inducing chemotherapy combined with a nanoSenolytic
Irene Galiana et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Clearance of therapy-induced senescent tumor cells by the senolytic ABT-263 via interference with BCL-XL-BAX interaction
Tareq Saleh et al.
MOLECULAR ONCOLOGY (2020)
Senescent Cells in Cancer Therapy: Friends or Foes?
Boshi Wang et al.
TRENDS IN CANCER (2020)
Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after Dormancy
Tareq Saleh et al.
CANCER RESEARCH (2019)
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Hubert Fleury et al.
NATURE COMMUNICATIONS (2019)
447PDPhase I/II study of combined BCL-XL and MEK inhibition with navitoclax (N) and trametinib (T) in KRAS or NRAS mutant advanced solid tumours
R B Corcoran et al.
ANNALS OF ONCOLOGY (2019)
Connecting cancer relapse with senescence
Olivier Pluquet et al.
CANCER LETTERS (2019)
Cellular Senescence: Defining a Path Forward
Vassilis Gorgoulis et al.
CELL (2019)
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang et al.
NATURE (2019)
Tumor cell escape from therapy-induced senescence
Tareq Saleh et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
Agnieszka Bojko et al.
CELLS (2019)
Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis
Claire N. Harrison et al.
BLOOD (2019)
The dynamic nature of senescence in cancer
Soyoung Lee et al.
NATURE CELL BIOLOGY (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
The curcumin analog EF24 is a novel senolytic agent
Wen Li et al.
AGING-US (2019)
Cellular senescence: a promising strategy for cancer therapy
Seongju Lee et al.
BMB REPORTS (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model
Ying-Chun Shen et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
High-Speed Live-Cell Interferometry: A New Method for Quantifying Tumor Drug Resistance and Heterogeneity
Dian Huang et al.
ANALYTICAL CHEMISTRY (2018)
Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation
Xingui Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Michael J. Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Jonathan F. Anker et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Marco Demaria et al.
CANCER DISCOVERY (2017)
Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer
Hirotoshi Kawata et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang et al.
CELL REPORTS (2017)
Unmasking Transcriptional Heterogeneity in Senescent Cells
Alejandra Hernandez-Segura et al.
CURRENT BIOLOGY (2017)
Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line
Paola Ortiz-Montero et al.
CELL COMMUNICATION AND SIGNALING (2017)
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Jianhui Chang et al.
NATURE MEDICINE (2016)
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
Yi Zhu et al.
AGING CELL (2016)
Discovery of piperlongumine as a potential novel lead for the development of senolytic agents
Yingying Wang et al.
AGING-US (2016)
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
Claire L. Vale et al.
LANCET ONCOLOGY (2016)
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence
Priyanka L. Patel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells
Moureq Alotaibi et al.
RADIATION RESEARCH (2016)
Understanding Mechanisms of Resistance in Metastatic Castration-resistant Prostate Cancer: The Role of the Androgen Receptor
Derya Tilki et al.
EUROPEAN UROLOGY FOCUS (2016)
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells
D. J. Barakat et al.
ONCOGENE (2015)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D. Leverson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1
Barbara Jonchere et al.
ONCOTARGET (2015)
Forging a signature of in vivo senescence
Norman E. Sharpless et al.
NATURE REVIEWS CANCER (2015)
Sustained activation of DNA damage response in irradiated apoptosis-resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers
Zhanna V. Chitikova et al.
CELL CYCLE (2014)
The role of senescent cells in ageing
Jan M. van Deursen
NATURE (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Alexandre Iannello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells
Dominick G. A. Burton et al.
PLOS ONE (2013)
Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo
Jonathan A. Ewald et al.
PROSTATE (2013)
Navitoclax (ABT-263) Reduces Bcl-xL-Mediated Chemoresistance in Ovarian Cancer Models
Maureen Wong et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Yu Sun et al.
NATURE MEDICINE (2012)
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
C. Canino et al.
ONCOGENE (2012)
Survivin and escaping in therapy-induced cellular senescence
Qin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Darren J. Baker et al.
NATURE (2011)
Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2
Zuzana Pernicova et al.
NEOPLASIA (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Protocols to detect senescence-associated beta-galactosidase (SA-beta gal) activity, a biomarker of senescent cells in culture and in vivo
Florence Debacq-Chainiaux et al.
NATURE PROTOCOLS (2009)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line
PA Watson et al.
CANCER RESEARCH (2005)
A retrospective study of the time to clinical endpoints for advanced prostate cancer
N Sharifi et al.
BJU INTERNATIONAL (2005)
Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers
RS Roberson et al.
CANCER RESEARCH (2005)
Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: Implications for treatment response
LW Elmore et al.
CLINICAL CANCER RESEARCH (2005)
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging
A Krtolica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
